xRcovid

With a smartphone and an RDT, this solution allows authorities to test and track the prevalence of the virus. The smartphone takes a picture of an RDT, and the AI of the app then ensures the conformity of the test. It reads and interprets the result for the user, and displays whether the test is positive, negative or inconclusive. We can:
- Guarantee the reliability of the test and the clarity of the result
- Ensure compliance of rapid diagnostic tests (RDTs)
- Log the results of hundreds of thousands of tests, and understand in real time where the hotspots are. This allows authorities to make smart decisions about where to put resources and where to consider lifting restrictions. We can help create and ensure covid-19 free spaces. It allows for real time the data related to the spread of the virus, guaranteeing clear results and consistent tests, whilst protecting personal data.

We can underline 3 main problems:
The first one relies on security. Currently there are many serology rapid diagnostic tests but their results are uneven. Some of them are reliable and some can detect the antobodies less than 50% of the time. Therefore there is firstly a need of securing this tests.
The second problem is the traceability of the results. Health authorities need those results to be able to track the virus and get an understanding of the spread and prevalence of the virus.
Finally mass testing is the key, everyone deserve to know their covid status to protect themselves and the others. As mentioned by WHO, testing is the solution. Our solution will benefit everyone, from individuals, companies, health workers to authorities. "

It is an application that reads RDTs (Rapid Diagnostic Tests), and is able to accurately identify whether a person has a virus (in this case Covid-19) or not. We were able to develop this with our patented Artificial Intelligence technology.

The solution can serve everyone, anywhere. What we want to accomplish is uniform mass testing. A quick and simple solution to knowing whether Covid-19 is prevalent or not. From hospitals to homes, to airports, we can provide a secure, cheap and quick solution to ensuring the safety of all. The impact this will have, is guaranteeing that everyone is healthy and able to proceed with their day to day lives as well as allowing a quick and informed response for those who are infected. In addition to people being able to get their results within a matter of minutes, the government will be able to geolocalize this data and have real-time information pertaining to the spread or lack thereof of the virus.

Our creed was always to improve people's lives with AI, and in light of Covid-19 we have developed xRcovid to serve as a tool in detecting and monitoring the virus. We can provide secure information to both the user and the government in a matter of minutes. We ensure the uniformity of the tests, allowing for certainty in the outcome and clarity for the reader.

ith this technology being already developed, we will be able to quickly adjust and make changes for any future outbreaks or new viruses, so that we can more efficiently test and eradicate the virus.

Our use of our patented Artificial Intelligence to guarantee the results of RDTs is what makes our solution so innovative. The use of and deployability of app for mass scale testing is also a unique attribute to our solution. We take away a lot of difficulties in the process of acquiring quick, cheap, reliable, traceable and secure results and we allow for results to be available within minutes.

We rely on AI to interpret the results of RDTs through image recognition, and assisted machine learning.

We are in the process of submitting an academic paper, through/with a teaching hospital in Paris that proves the accuracy of our app in reading the results of an RDT.

As for most diseases, testing and targeted responses are the way to eradicate. Our solution brings both the ability to mass test easily, quickly and to have instant traceability of any outbreaks. This enables to target our response to where its most needed.

Currently serving - 50
In one year - Tens of thousands
In five years - Hopefully none [as we hope to eradicate viruses], otherwise it will be available to serve everyone

In the future, our plan is to be able to provide quick, mass testing for any potential pandemic. We also plan to incorporate our existing technology and all of our research into our new award winning product: xRblood - the first at-home blood self-testing device, that is able to provide lab quality results at the touch of a button. Currently in the stages of development, it can perform full blood-count analysis through amazing machine learning. Initially to be launched with healthcare professionals, with the end goal of being in the home those who require regular testing, or are unable to eaily access healthcare professionals.

We don't see any barriers except being able to deploy quickly to many locations and therefore having the finance for it

By winning this challenge

26 staff - 5 contract/intern

We are one of the leading startup AIs for automated diagnostics

Paris and Marseille teaching hospitals. They have been deploying our app from the start to help us calibrate and train the Artificial Intelligence.

xRcovid is distributed free of charge to public health authorities and under a paid license to private companies

We need to reach critical mass of B2B users to finance those who we provide the solution for free of charge

We need exposure to key stakeholders to showcase our mission and to help our deployment

We hope to get more global exposure so that we can implement this solution in as many places as possible

We would like to partner with experts in the field of imagery and artificial intelligence